Your session is about to expire
← Back to Search
Pharmacist-Led care for Hepatitis C (PHARM-C Trial)
PHARM-C Trial Summary
This trial is testing whether it's more effective to treat hepatitis C in a community pharmacy than referring patients to a hospital.
- Hepatitis C
PHARM-C Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PHARM-C Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Community Pharmacist-Led
- Group 2: Academic hepatology
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently involved in this clinical research?
"Affirmative. Clinicaltrials.gov has the most recent information on this study, which was published on April 13th 2022 and revised 6 days later. This trial is currently recruiting 108 participants from a single location."
Are there any openings for candidates to join this clinical trial presently?
"Affirmative, the information located on clinicaltrials.gov states that this medical trial is currently looking for participants. The initial posting was April 13th of 2022 and it has been updated recently as of April 19th. 108 patients need to be recruited from just one center."
May I be included in the current clinical trial?
"Criteria for participation in this trial require those affected by hepatitis c to be aged between 18 and 80. Approximately 108 individuals are being looked for to take part."
Has the Federal Drug Administration sanctioned Pharmacist-Led care?
"The safety of pharmacist-led care has been validated in phase 4 trials, and thus is rated as 3 out of a possible 3 on our scale."
Does this research endeavor include elderly participants aged 85 and over?
"The parameters of this trial dictate that all participants must be aged 18 to 80. There are an additional 27 studies available for minors and 236 studies suitable for elderly patients."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger